Anxiety State, Depression, Infertility, Female, Quality of Life, Sexual Function and Fertility Disorders
Conditions
Brief summary
Women's quality of life, sexual life and psychological state would affect the success of embryo transfer. The primary purpose of the study is to compare women's quality of life, sexual life and psychological state using validated forms between those undergoing fresh embryo transfer and those undergoing frozen embryo transfer.
Detailed description
There are two types of embryo transfers; fresh and frozen embryo transfers. Studies have been conducted to compare success rates between fresh and frozen embryo transfers. However, most studies have not taken into consideration women's quality of life, sexual life and psychological state in comparing fresh embryo transfer with frozen embryo transfers. These all parameters are confounding factors that may influence the success of embryo transfer. The purpose of this study is to compare women's quality of life, sexual life and psychological state using validated forms between those undergoing fresh embryo transfer and those undergoing frozen embryo transfer. The following forms will be used: expanded version of the inventory of depression and anxiety symptoms (IDAS-II), Beck Anxiety inventory (BAI), Short Form Survey (SF-36) and Female Sexual Function Index (FSFI. This study can provide evidence regarding the association between women's quality of life, sexual life and psychological state and embryo transfer success.
Interventions
OTHERFilling out the forms including IDAS-II, BAI, SF-36 and FSFI
Participants will fill out certain validated forms including the expanded version of the inventory of depression and anxiety symptoms (IDAS-II), Beck Anxiety inventory (BAI), Short Form Survey (SF-36) and Female Sexual Function Index (FSFI).
Sponsors
Uskudar University
Bahceci Health Group
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 39 Years
Healthy volunteers
Yes
Inclusion criteria
* Age between 20 - 39 years * Body mass index between 18 -3 5 kg/m2 * Anti-mullerian hormone levele \>1.1 ng/ml or antral follicle count \> 8 * fresh or frozen embryo transfer using middle-quality or good-quality day 3 or 5 embryos
Exclusion criteria
* Age below 20 or over 39 years * Uterine malformations * Hypo or hyperthyroidism * Diabetes mellitus * Previous history of psychiatric disorders * Use of psychiatric medications * Systemic disorders (hypertension, chronic liver/kidney/heart problems)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical pregnancy rate | At around 7 weeks of gestation | Clinical pregnancy is defined as the presence of intrauterine fetal heartbeat at around 7 weeks of gestation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Implantation rate | At around 6 weeks of gestation | Implantation is defined as presence of intrauterine gestational sac at around 6 weeks of gestation. |
| Live birth rate | 24 completed weeks of gestation | Live birth is defined as at least a live birth after 24 completed weeks of gestation. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactMehmet Resit Asoglu, Ass. Prof
Backup ContactCem Celik, Prof
Outcome results
None listed